Skp1 is a cytoplasmic and
nuclear protein of eukaryotes best known as an adaptor in SCF
ubiquitin-
protein isopeptide
ligases. In Dictyostelium, Skp1 is subject to 4-hydroxylation at Pro(143) and subsequent O-glycosylation by alpha-linked GlcNAc and other
sugars. Soluble cytosolic extracts have Skp1
prolyl 4-hydroxylase (P4H) activity, which can be measured based on hydroxylation-dependent transfer of [(3)H]GlcNAc to recombinant Skp1 by recombinant (Skp1-protein)-hydroxyproline alpha-N-acetyl-d-glucosaminyltransferase. The Dictyostelium Skp1 P4H gene (phyA) was predicted using a bioinformatics approach, and the expected
enzyme activity was confirmed by expression of phyA
cDNA in Escherichia coli. The purified recombinant
enzyme (P4H1) was dependent on physiological concentrations of O(2),
alpha-ketoglutarate, and ascorbate and was inhibited by
CoCl(2),
3,4-dihydroxybenzoate, and 3,4-dihydroxyphenyl
acetate, as observed for known animal cytoplasmic P4Hs of the
hypoxia-inducible factor-alpha (HIFalpha) class. Overexpression of phyA
cDNA in Dictyostelium yielded increased
enzyme activity in a soluble cytosolic extract. Disruption of the phyA locus by homologous recombination resulted in loss of detectable activity in extracts and blocked hydroxylation-dependent glycosylation of Skp1 based on molecular weight analysis by SDS-PAGE, demonstrating a requirement for P4H1 in vivo. The sequence and functional similarities of P4H1 to animal HIFalpha-type P4Hs suggest that hydroxylation of Skp1 may, like that of animal HIFalpha, be regulated by availability of O(2),
alpha-ketoglutarate, and ascorbate, which might exert novel control over Skp1 glycosylation.